Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial.
Tirzepatide combined with healthy lifestyle changes significantly reduced BMI in adolescents with obesity, offering a new treatment option for this growing population.
This PubMed record examines Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial. It reports CONCLUSIONS AND RELEVANCE: In adolescents with obesity or overweight with obesity-related complications, tirzepatide, in addition to healthy lifestyle intervention, led to significant reductions in percent change in BMI compared with placebo at 72 weeks.
What the study was
- Study design
- Phase 3 randomized controlled trial
- Population
- Human participants
- Category
- Public Health
- Maturity
- Validated
- Journal
- JAMA
Why it surfaced
Phase 3 randomized controlled trial; conservative rapid-triage score based on PubMed title, publication type, and abstract.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.